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The study examined prevalence, awareness, treatment and control of hypertension (HTN), and associated factors and to evaluate
the trend in hypertension between 2009 (period 2) and 1994–1998 (period 1). A national sample of 4117 adults aged 25 years and
older was selected. Prevalence rate of HTN (SBP ≥ 140 or DBP ≥ 90 or on antihypertensive therapy) was 32.3% and was higher
than the 29.4% prevalence rate reported in period 1. Prevalence rate was signiﬁcantly higher among males, older age groups, least
educated, obese, and diabetics than their counterparts. The rate of awareness among hypertensives was 56.1% and was higher than
the 38.8% rate reported form period 1 data. Awareness was positively associated with age, smoking, and diabetes for both men
and women, and with level of education and body mass index for men. Rate of treatment for HTN among aware patients was
63.3% and was signiﬁcantly higher than the 52.8% rate reported in period1. Control rate of HTN among treated hypertensives was
39.6%; signiﬁcantly higher than the 27.9% control rate in period 1. Control of HTN was positively associated with age but only
for women. In conclusion, HTN is still on the rise in Jordan, and levels of awareness and control are below the optimal levels.
1.Introduction
HTNisamajorpublichealthproblemofworldwidedistribu-
tion and is the most common cardiovascular disease (CVD)
risk factor [1]. It is responsible for one half of coronary
heart disease (CHD) and about two thirds of cerebrovascular
accidents [2]. By 2030, 23 million cardiovascular deaths are
projectedtohaveHTN,withabout85%occurringinlowand
middle-income countries [1]. Research published between
1980 and 2002 indicate the prevalence of HTN in developing
countries increased at a higher rate than in developed coun-
tries [3]. Prevention of HTN is possible, and early detection
and treatment can reduce the incidence of complications
including stroke, CHD, heart failure, and kidney disease
[4], and yet the levels of control of hypertension are low
worldwide. Economically developed countries have higher
rates of HTN than in developing countries [5]. However,
data reported in the last decade indicate that the prevalence,
awareness, treatment, and control of hypertension in eco-
nomically developing countries are coming closer to those in
economically developed countries [6].
Recent epidemiological studies on prevalence, awareness,
treatment, and control of HTN in Jordan are scarce. The
fewcommunity-basedstudies[7,8]conductedbetween1994
and 1996 in Jordan demonstrated a 16.1 and 16.3% preva-
lence rates of HTN (cut-oﬀ point 160/90mm Hg) with
concomitant low levels of awareness, treatment, and control.
Since that time, several activities have been implemented to
face this challenge in HTN which have not been evaluated.
Moreover, the last decades showed a remarkable improve-
ment in treatment of hypertension due to introduction of
new antihypertensive medications and the development of
international guidelines for detection and management [9,
10]
This paper was conducted to assess the prevalence,
awareness, treatment, and control of HTN using data from2 International Journal of Hypertension
a 2009 national population survey and to examine the trend
in HTN in Jordan by comparing these data with a pooled
community-based data collected during the period between
1994 and 1998 in Jordan.
2.MaterialsandMethods
This study is a subset of a national population-based house-
hold survey that was conducted during the period between
July 1st and November 30, 2009. Details of the sampling and
data collection were reported elsewhere [11, 12]. Brieﬂy, a
complex multistage sampling technique was used to select
the households from the 12 governorates of Jordan. Each of
the selected households was visited by members of the study
team,and,afterbeeninformedofthepurposeofthestudy,all
members aged ≥7 years were invited to report to the health
center in their catchment area centre in the next day after an
overnight fast. Subjects on regular medications were asked
not to bring all their medications with them to the survey
site. The present study deals exclusively with adults aged ≥25
years.
Interview questionnaire was administered by trained in-
terviewers and gathered information and speciﬁc history on
HTN, DM, lipids, smoking behavior, and other socio-dem-
ographic characteristics. Anthropometric measurements in-
cludingweight,heightweremeasuredwiththesubjectswear-
ing light clothing and no shoes. Body mass index (BMI) was
calculated as the ratio of weight in kilograms to the square
of height in meters. BP was measured using standardized
mercury sphygmomanometer with the appropriate cuﬀ that
covers two-thirds of the upper arm. A physician or trained
nurse performed the BP measurement with the subject being
in the sitting position, the arm at the level of the heart, and
after 5 minutes rest. The cuﬀ was inﬂated at a rate of 2-
3mmHgpersecond.Systolicbloodpressure(SBP)wastaken
upon hearing the ﬁrst sound, and diastolic blood pressure
(DBP) was taken upon complete disappearance of Korotkoﬀ
sounds (phase V). HTN was deﬁned as SBP ≥ 140mmHg
and/or DBP ≥ 90mmHg and/or use of antihypertensive
medication. Hypertensive subjects were considered aware
of HTN when having been told by a physician during the
last year that they have hypertension or when report taking
antihypertensive medication. Participants were considered
to be treated for HTN when report using antihypertensive
medication. HTN control was deﬁned as SBP < 140mmHg
and DBP < 90mmHg among treated patients. Body mass
Index (BMI) was calculated by dividing the weight in
kilogram on the height in meters squared. Participants with
BMI of 30kg/m2 or more were considered obese, while those
withBMIvalues thatrangebetween 25kg/m2 and <30kg/m2
were considered overweight. HTN prevalence was age-sex
adjusted by direct standardization to the Jordan 2004 stand-
ard population.
To examine trends in prevalence, awareness, and control
of hypertension we pooled data from previously published
[7, 8, 13] and unpublished population-based surveys con-
ducted over the 1994–1998 period. The primary focus of
those surveys was on cardiovascular disease risk factors
among adults 25 years of age and older. Details of the
sampling and data collection of those surveys are presented
elsewhere [7, 8, 13]. Brieﬂy, a systematic sampling technique
was used to select the households from six communities
located in the North, South, Middle, and East of Jordan and
of approximately 80,000 inhabitants. The procedures used
in those surveys, including training of study teams, home
visits, invitation of eligible participants, consenting, settings
(primaryhealthcarecentersofMinistryofHealth),interview
questionnaire, veriﬁcation of antihypertensive medications,
application of physical measures of blood pressure, weight,
and height were identical to the procedures used in the 2009
study. A total of 3905 individuals who participated in those
surveys were included in the analysis with a response rate
ranging between 45% and 78%.
3.StatisticalAnalysis
Statistical analyseswereperformedusing the Statistical Pack-
age for Social Sciences software, SPSS (SPSS Inc., Chicago,
Ill, USA) version 16. Frequency distribution was used to
describe the dichotomous variable of hypertension preva-
lence, awareness, treatment, and control with the other
categories of participants’ characteristics. Bivariate analyses
were performed to test for independent distribution of
participants’ characteristics among levels of hypertension
using χ2 test. The odds ratios (OR) and their P values
wereestimatedbyperformingmultivariatelogisticregression
models to test the association between hypertension and
certain sociodemographic, behavioral, and health character-
istics of participants.
To examine the trend in hypertension, data on 3905 par-
ticipants gathered during the period 1 were compared with
period 2 data. Bivariate comparisons were performed to test
for the independent distribution of hypertension and other
participants’ characteristics by study period using χ2 test. A
P value of ≤0.05 was considered statistically signiﬁcant.
4. Results
In 2009, a total of 4117 eligible individuals were included in
the analysis, with a response rate of 68%. The main reasons
behind nonparticipation were inability to leave from work
or to remain fasting prior to blood tests. As with period 1
surveys, the response rate was signiﬁcantly higher among
women than among men, dictating the need for sex-speciﬁc
analysis of data.
AsshowninTable 1,aboutone-third(30.5%)ofthesam-
ple were 50 years of age and older, 25.4% were males, 43.6%
were either illiterate or with <High School (HS) diploma,
32.2% were holding college diploma or higher, 45.5% have
a family monthly income of <500 US$, and 86.3% have <850
US$ per month. Table 1 also shows that 16% were current
smokers, 35.3% were overweight, 45.1% obese, 16.4% dia-
betics, and 54.2% had high levels of serum cholesterol.
Of the 4117 participants, a total of 1329 (32.2%)
were categorized as having HTN. Table 1 indicates that the
prevalence rate of HTN is signiﬁcantly higher among malesInternational Journal of Hypertension 3
Table 1: Hypertension prevalence, awareness, treatment, and control by sociodemographic and health variables of the 2009 survey (N =
4117)∗.
Variables N (%) Prevalence, n (%) Awareness, n (%) Treatment, n (%) Control, n (%)
Overall 4117 1329 (32.3) 746 (56.1) 472 (63.3) 187 (39.6)
Age .00 .00 .00 .00
25–34 964 (23.4) 95 (9.9) 31 (32.6) 12 (38.7) 8 (68.8)
35–49 1899 (46.1) 460 (24.2) 208 (45.2) 118 (57.2) 57 (47.5)
50–64 962 (23.4) 563 (58.5) 358 (63.6) 241 (67.3) 91 (38.2)
65+ 292 (7.1) 211 (72.3) 149 (70.6) 101 (76.8) 31 (30.1)
Sex .01 .52 .01 .27
Men 1045 (25.4) 371 (35.5) 203 (54.7) 136 (67) 58 (42.9)
Women 3072 (74.6) 958 (31.2) 543 (56.7) 336 (61.9) 129 (38.2)
Education .00 .02 .78 .01
<high school 1781 (43.6) 793 (44.5) 469 (59.1) 298 (63.5) 109 (36.6)
High school 991 (24.2) 249 (25.1) 125 (50.2) 77 (61.6) 30 (38.5)
>high school 1315 (32.2) 270 (20.5) 142 (52.6) 90 (63.4) 48 (52.9)
Marital status .00 .00 .29 .00
Single 351 (8.5) 54 (15.4) 17 (31.5) 10 (58.8) 8 (84.6)
Married 3766 (91.5) 1275 (33.9) 729 (57.2) 462 (63.4) 179 (38.6)
Income (US$)∗∗ .00 .25 .28 .00
<500 1848 (45.5) 704 (38.1) 409 (58.1) 253 (61.9) 81 (32.2)
500–850 1659 (40.8) 467 (28.1) 254 (54.4) 165 (65) 79 (48.0)
>850 558 (13.7) 143 (25.6) 74 (51.7) 48 (64.9) 24 (50.8)
Current smoking .00 .08 .05 .04
No 3457 (84.0) 1159 (33.5) 640 (55.2) 410 (64.1) 156 (38.0)
Yes 660 (16.0) 170 (25.8) 106 (62.4) 62 (58.5) 31 (50.0)
BMI, kg/m2 .00 .01 .38 .1
<25 808 (19.6) 92 (11.4) 39 (42.4) 24 (61.5) 11 (43.8)
25–29 1453 (35.3) 369 (25.4) 199 (53.9) 122 (61.3) 56 (46.1)
30+ 1856 (45.1) 868 (46.8) 508 (58.5) 326 (64.2) 120 (36.8)
DM .00 .00 .4 .35
Absent 3442 (83.6) 681 (28.1) 310 (45.5) 198 (63.9) 78 (39.3)
Present 675 (16.4) 400 (61.8) 294 (73.5) 193 (65.6) 68 (35.4)
High cholesterol .00 .96 .01 .23
Absent 1887 (45.8) 505 (26.8) 283 (56.0) 170 (60.1) 72 (42.6)
Present 2230 (54.2) 824 (37.0) 463 (56.2) 302 (65.2) 114 (37.8)
∗Values on certain variables did not add up to 100% due to missing data.
∗∗Income: monthly income.
and the older age groups with a sharp rise in the 50 years and
older age groups. Participants with a lower level of education
and income, obesity, DM, and hypercholesterolemia have
signiﬁcantly higher rates of HTN than their counterparts.
The ﬁndings from sex-speciﬁc multiple logistic regression
analysis indicate that increasing age and BMI, the presence
of DM, and the lowest level of education were independently
signiﬁcantly associated with HTN, but no evidence of a
signiﬁcant association with income, smoking, and high
serum cholesterol was found for either men or women
(Table 2).Formen,theriskofhavingHTNfortheagegroups
50–64 years and 65+ years is 3.5 and 7.2 times, respectively,
compared to the youngest age group, while the risk of HTN
for women in the same age groups is 7.3 and 14.1 times,
respectively, compared to the youngest age group (Table 2).
Of the 1329 hypertensive 2009 participants, 746 (56.1%)
were aware of having hypertension. As indicated in Table 1,
rate of awareness signiﬁcantly increases with age, BMI,
lowest level of education, marriage, and presence of DM.
Results of sex-speciﬁc multiple logistic regression analysis
are depicted in Table 2. For men, awareness independently
correlates positively with the older age group, highest level of
education, smoking, obesity, DM,and hypercholesterolemia;
no association was detected with marital status or income.
For women, awareness independently correlates positively
with age, smoking, and DM; no association was detected4 International Journal of Hypertension
Table 2: Adjusted odds ratio (OR) and their P values of predictors of hypertension prevalence and awareness by sex.
Prevalence Awareness
Variables Men Women Men Women
OR P value OR P value OR P value OR P value
Age
25–34 1 1 1 1
35–49 1.17 .59 2.32 .00 .65 .43 1.94 .03
50–64 3.55 .00 7.34 .00 2.25 .13 3.05 .00
65+ 7.18 .00 14.1 .00 3.61 .03 4.37 .00
Education
<high school 1 1 1 1
High school .84 .35 .84 .15 1.24 .5 1.12 .57
>high school .66 .04 .69 .01 2.13 .02 1.19 .44
Marital status
S i n g l e 1111
Married 1.04 .92 1.4 .09 1.84 .47 2.21 .89
Income∗∗
<3 0 0 1111
300–599 1.28 .15 .82 .07 .83 .49 .94 .71
600+ 1.16 .56 .99 .94 .48 .08 1 .99
Current smoking
N o 1111
Yes .9 .23 .91 .21 2.27 .00 1.83 .02
BMI, kg/m2
<2 5 1111
25–29 2.72 .00 1.7 .00 1.75 .21 1.21 .55
30+ 5.52 .00 3.74 .00 2.78 .02 1.33 .35
DM
A b s e n t 1111
Present 1.63 .02 2.57 .00 1.98 .02 3.56 .00
High cholesterol
A b s e n t 1111
Present 1.21 .21 1.05 .65 .54 .02 1.02 .89
witheducation,maritalstatus,income,BMI,orhypercholes-
terolemia.
Of the 746 hypertensive individuals aware of having
HTN, 472 (63.3%) were on antihypertensive treatment
(Table 1). Older patients, males, nonsmokers, and patients
with hypercholesterolemia are signiﬁcantly more likely to
receive treatment for HTN than their counterparts. Sex-
speciﬁc multiple logistic regression analysis indicates that
increased age for men and women and income for women
were signiﬁcantly associated with receiving treatment for
HTN; no signiﬁcant association was found with educational
attainment, smoking, BMI, DM, and hypercholesterolemia
(Table 3).
Among the 472 of the 2009 hypertensive participants
who were on antihypertensive medications, 187 (39.6) had
controlled HTN. Univariate analysis shows that older, more
educated, more aﬄuent, and smokers have signiﬁcantly
higher rates of controlled HTN than their counterparts
(Table 1). The ﬁndings from sex-speciﬁc multivariate logistic
regression analysis indicated that only women in the age
groups 50 years and older were signiﬁcantly more likely to
have controlled HTN than those in the age group 25–34
years; no signiﬁcant association was found with education,
smoking, BMI, DM, and hypercholesterolemia for both men
and women (Table 3).
To examine the trend in HTN prevalence, awareness,
treatment, and control among Jordanian adults, we com-
pared the 1994–1998 (period 1) data with the 2009 (period
2) data. Bivariate analysis show no signiﬁcant diﬀerences in
age and gender of the participants in the two periods but
BMI was signiﬁcantly higher among period 2 participants
(P value = .00) (Table 4). As indicated in Table 4, prevalence
rate of HTN had increased from 29.4% in period 1 to 32.3%
in period 2 (P value = .00) (31.2% versus 35.5% for men,
and 28.3% versus 31.2% for women). Data also show that
awareness of HTN in period 2 increased from 38.8% toInternational Journal of Hypertension 5
Table 3: Adjusted odds ratio (OR) and their P values of predictors of hypertension treatment and control by sex.
Treatment Control
Variables Men Women Men Women
OR P value OR P value OR P value OR P value
Age
25–34 1 1 1 1
35–49 7.82 .02 1.64 NS .64 NS 3.44 NS
50–64 64.78 .00 4.12 .01 .95 NS 5.24 .05
65+ 54.98 .00 5.2 .01 .86 NS 10.0 .01
Income∗∗
<3 0 0 1111
300–599 .69 NS 1.97 .03 .62 NS .66 NS
600+ .61 NS 2.3 .05 .73 NS .78 NS
Education, marital status, smoking, BMI, DM, and High cholesterol variables were included in the treatment and control models and were statisticallyn o t
signiﬁcant.
Table 4: Distributionof prevalence, awareness, treatment and control of hypertension, and sociodemographic characteristics of participants
by study period.
Variable Period 1 Period 2 P value
N%N%
Age
<40 1619 (41.5) 1626 (39.5)
40+ 2286 (58.5) 2491 (60,5) .1
Sex
Male 1545 (39.1) 1548 (37.6)
Female 2360 (60.9) 2569 (62.4) .1
BMI
<25 957 (24.5) 701 (17)
25–29.9 1335 (34.2) 1392 (33.8)
30+ 1613 (41.3) 2024 (49.2) .00
Prevalence 1148 (29.4) 1329 (32.3) .00
Awareness 445 (38.8) 746 (56.1) .00
Treatment 234 (52.8) 472 (63.3) .00
Control 65 (27.9) 187 (39.6) .00
56.1% in period 2 (P value = .00) (31.7% versus 54.5%
for men, and 45.9% versus 57.7% for women). The rate
of antihypertensive therapy among aware patients increased
from 52.8% in period 1 to 63.3% in period 2 (P value
= .00) (52.5% versus 87.4% for men, and 53% versus 83.4%
for women). Among patients receiving antihypertensive
treatment, the control rate of HTN increased from 27.9% in
period 1 to 39.6% in period 2 (P value = .00) (28.3% versus
44.4% for men, and 27.5% versus 38.2% for women).
5. Discussion
This is the ﬁrst national survey conducted to examine the
prevalence, awareness, treatment, and control of HTN and
their associated factors among Jordanian adults.
Study data indicate that about one-third of adult Jorda-
nians aged 25 years and older are aﬄicted with HTN. The
32.2% prevalence rate of HTN reported in this study is in
the upper range of the 26.1%−32.1% ﬁgures reported from
other Arab countries [14–17], lower than the 42%–44.9%
rate reported in Eastern Europe [18, 19], the 36%–55% rates
reported in other western European countries [20–22], and
the 35.8% rate reported in Australia [23], but is higher than
the 27%-28% rates reported in China [24], Canada, and the
United States [19]. Variations in prevalence rates of HTN
by regions could be attributed to several factors including
changes in lifestyle associated with urbanization, ethnic
diﬀerences,nutritionalstatus,birthweight[25],variationsin
study designs, the age range included in the study, the time
period of the study, and the type of blood pressure machines
used. The high prevalence rate of HTN in Jordan could
be partially attributed to the epidemic of obesity among
Jordanians, adoption of western lifestyle [26], and to the fact
that >80% of the population lives in urban areas. Moreover,
the population of Jordan has witnessed extremely stressful6 International Journal of Hypertension
conditions, starting with the exodus of Palestinians to Jordan
during the 1948 Arab-Israeli war, followed by another wave
of migration of masses of Palestinians from the West Bank of
JordantoJordanduring1967Arab-Israeliwar,andbyathird
wave of immigration of approximately 350,000 Jordanians
(about 9% of the total population of Jordan at that time)
from the Arabian Gulf States to Jordan during the 1991 Gulf
War. These conditions subjected the Jordanian population
to the full blown ramiﬁcations of social, psychological, and
economic stress that could have increased the rates of mental
and physical illness, including HTN.
The prevalence rate of HTN in 2009 was signiﬁcantly
higherthanitwasinthe1994–1998period.Thisdiﬀerencein
HTN prevalence remained signiﬁcant even after controlling
for the eﬀect of BMI (data not reported). This trend is in
line with the secular increase in the HTN prevalence in
economically developing countries [26–28]. Consistent with
the ﬁndings from several studies, HTN was positively as-
sociated with male gender [23, 29]a n da g e[ 7, 13, 14].
However, in older age groups, the risk of having HTN rises
moredramaticallyamongfemalesthanmales,especiallyafter
the age of 50 years. In their study of trends in hypertension
in the MONICA project, Gasse et al. [30] concluded that “...
in advanced age the increase in the rate of hypertension is
steeper in women than in men.” In line with the ﬁndings
from other research, HTN is positively associated with BMI
[29]. Moreover, study data show that overweight and obese
men are at higher risk of developing HTN than women
of the same weight categories, a ﬁnding that is supported
in the literature [31, 32]. Our study indicates that HTN is
inversely associated with level of education [33, 34]. Highly
educated people are usually well informed about health
issues including HTN and more prone to adopt healthy
lifestyle habits such as a healthy diet, exercise, and the
maintenance of an ideal body weight. Moreover, educated
people maintain a greater sense of control over their lives
and a tend to have a greater level of social support than those
with a lower level of education [35]. Data in this study shows
that HTN is positively associated with DM, a ﬁnding that is
highly supported in the research literature [36]. Moreover,
the odds ratio of HTN was higher in diabetic women than in
diabetic men. To our knowledge, there is no existing research
examining the sex diﬀerences in HTN among diabetics.
However, meta-analysis studies [37, 38] indicate that the
odds of CHD mortality were signiﬁcantly higher among
diabetic women, as compared with diabetic men.
Comparedtoperiod1data,therateofawarenessofHTN
has increased by 45% in period 2 (38.8% for men versus
56.1%forwomen).Despitethefactthatthe56.1%awareness
rate of HTN in Jordan is higher than the rates reported from
othercountries [25,29,36],itisstillfarbelowthanthe63%–
82.5% rates reported from developed countries [2, 20, 39].
Awareness in this study is positively associated with female
gender. This ﬁnding is strongly supported in the research
literature [2, 20, 23, 40]. It appears from this study that age is
positively associated with awareness of HTN among women
but only starts to show a positive eﬀect after the age of 65 for
men. On the other hand, awareness was positively associated
with the highest level of education for men, whereas no such
association was found for women. Coexistence of other CVD
risk factors (smoking, obesity, DM, and high levels of serum
cholesterol) is positively associated with awareness of HTN
for men, but only DM and smoking are positively associated
with awareness for women. People have recently become
more aware of CVD risk factors, and the presence of one or
more risk factors increases the tendency for those patients
and/or their treating physicians to check for the presence of
otherriskfactors,includingHTN.Theabsenceofassociation
between awareness of HTN and obesity and high serum
cholesterol among women is perhaps related to the fact that
the illiteracy rate is >3 times higher among women than
men(12.5%versus3.8%),thusdecreasingthelikelihoodthat
women will be better informed of the association between
those CVD risk factors with HTN.
The present study indicates that the rate of treatment
of HTN among those aware of having HTN increased from
52.4% in period 1 to 63.3% in period 2. This rate is
comparable to the 61.4%–82.5% treatment rates reported
from developed countries [2, 3, 20, 36, 39]. In line with
ﬁndings from other studies [3, 36], the rate of treatment is
positively associated with age. Older subjects are more in-
clined to be compliant with the medications prescribed for
them [36].
Data in this study show that the rate of control of HTN
among those receiving antihypertensive medications has in-
creased from 27.9% in period 1 to 39.6% in period 2. This
rate is comparable to the 35.1%–66.4% control rates re-
ported from economically developed countries [1, 2, 23, 39].
In conclusion, it is evident that hypertension is a com-
mon public health problem in Jordan and is still on the
rise. Awareness, treatment, and control of HTN have shown
considerable improvement over time but are still below the
optimal levels.
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